-
Auriga Upgrades Mettler-Toledo To Buy, $185 PT
Thursday, June 16, 2011 - 5:48am | 24Auriga has upgraded Mettler-Toledo International (NYSE: MTD) from Neutral to Buy and maintains its $185 price target.
-
Jefferies Raises PT On Mettler-Toledo To $215
Thursday, May 5, 2011 - 7:50am | 26Jefferies & Company has raised the price target on Mettler-Toledo (NYSE: MTD) from $200 to $215 and maintains its Buy rating.
-
UPDATE: Jefferies Color On MTD 4Q10
Friday, February 11, 2011 - 8:59am | 153Jefferies, which raised its PT on shares of Mettler-Toledo (NYSE: MTD), is providing some color on the firm. “MTD raised the mid-point of its formal 2011 EPS outlook by 4% (to $7.75) to account for the 4Q10 upside and a stronger organic revenue growth outlook (7% vs prior 5%), mitigated somewhat by...
-
JP Morgan Raises PT On Mettler-Toledo To $156
Friday, February 11, 2011 - 8:59am | 26JP Morgan has raised the price target on Mettler-Toledo (NYSE: MTD) from $148 to $156 and maintains its Neutral rating.
-
Jefferies Raises PT On Mettler-Toledo To $185
Friday, February 11, 2011 - 8:35am | 26Jefferies & Company has raised the price target on Mettler-Toledo (NYSE: MTD) from $160 to $185 and maintains its Buy rating.
-
JP Morgan Downgrades Mettler-Toledo To Neutral
Tuesday, January 4, 2011 - 7:50am | 25JP Morgan has downgraded Mettler-Toledo International (NYSE: MTD) from Overweight to Neutral and maintains its $148 price target.
-
Mettler-Toledo Reports Exceptional 3Q
Friday, November 5, 2010 - 8:44am | 170JP Morgan has published a research report on Mettler-Toledo International (NYSE: MTD) after the company reported exceptional 3Q results. In the report, JP Morgan writes "with revenues of $490M, +14% LC, exceeding both our $469M, +6.0% est., and consensus ($457M), while 52.2% GMs (+54 bps y/y) and...
-
Life Sciences Research From Jefferies
Monday, September 27, 2010 - 8:52am | 197Jefferies & Co. has published a research report for Life Sciences, reporting: "Median short interest for listed and OTC Life Science Research Supply stocks rose 1% from the second half of August, while aggregate short interest levels were essentially unchanged (vs. a 1% increase for Nasdaq and...